Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
ALBPS | PA
Overview
Corporate Details
- ISIN(s):
- FR0012816825 (+4 more)
- LEI:
- 9695008GIE061NBGU106
- Country:
- France
- Address:
- 14 AVENUE DE L'OPERA, 75001 PARIS
- Website:
- https://www.biophytis.com/en/
Description
Biophytis S.A. is a clinical-stage biotechnology company focused on developing therapeutics to slow degenerative processes associated with aging and improve longevity. The company's primary strategy is centered on treating diseases that impair mobility. Its lead drug candidate, BIO101, is being advanced in late-stage clinical development for multiple age-related conditions. A key program is the SARA Phase 3 trial, the first-ever pivotal study for the treatment of sarcopenia (age-related muscle loss). Additionally, BIO101 is being evaluated in the OBA Phase 2 clinical trial for addressing muscle wasting in patients with obesity. The company aims to preserve muscle function and enhance functional outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 07:00 |
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer…
|
French | 158.6 KB | ||
| 2025-08-28 07:00 |
Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarc…
|
English | 151.4 KB | ||
| 2025-08-05 23:00 |
Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 …
|
French | 111.1 KB | ||
| 2025-08-05 23:00 |
Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million
|
English | 115.7 KB | ||
| 2025-07-30 07:00 |
Biophytis rejoint Silver Innov', pépinière dédiée à la silver économy
|
French | 155.7 KB | ||
| 2025-07-30 07:00 |
Biophytis Joins Silver Innov', an Incubator Dedicated to the Silver Economy
|
English | 145.3 KB | ||
| 2025-07-16 07:00 |
Biophytis Wins Major Legal Victory Before the French Court of Cassation
|
English | 131.4 KB | ||
| 2025-07-15 07:00 |
Biophytis Partners in AI with Lynx Analytics to Accelerate Drug Discovery for S…
|
English | 560.3 KB | ||
| 2025-07-15 07:00 |
Biophytis s’associe à Lynx Analytics dans le domaine de l’IA pour accélérer la …
|
French | 559.6 KB | ||
| 2025-07-11 08:14 |
Biophytis Reports 2024 Financial Results and 2025 Outlook
|
English | 259.0 KB | ||
| 2025-07-11 08:14 |
Biophytis dévoile ses résultats 2024 et ses perspectives pour 2025
|
French | 284.9 KB | ||
| 2025-07-08 07:00 |
Biophytis au cœur de l’innovation dans la longévité à la conference World Aging…
|
French | 156.2 KB | ||
| 2025-07-08 07:00 |
Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuven…
|
English | 127.0 KB | ||
| 2025-07-07 07:00 |
Obésité : Biophytis Trace sa Voie vers un Marché en Pleine Explosion
|
French | 155.3 KB | ||
| 2025-07-07 07:00 |
Obesity: Biophytis Charts Its Course Toward a Booming Market
|
English | 138.4 KB |
Automate Your Workflow. Get a real-time feed of all Biophytis S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biophytis S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biophytis S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-22 | N/A | Other | Buy | 8,443,190 | 79,365.99 EUR |
| 2020-12-16 | N/A | Other | Sell | 500,000 | 499,000.00 EUR |
| 2020-12-16 | N/A | Other | Other | 313,417 | N/A |
| 2020-04-30 | N/A | Other | Other | 2,955,701 | 177,342.06 EUR |
Peer Companies
